24 / 30
allied
academies
Page 76
Note:
Journal of Gastronenterology and Digestive Diseases
|
Volume 3
J u n e 2 5 - 2 6 , 2 0 1 8 | D u b l i n , I r e l a n d
GASTROENTEROLOGY
International Conference on
NON-ALCOHOLIC FATTY LIVER DISEASE
Maisam Akroush
Prince Hamzeh Hospital, Jordan
N
on-alcoholic fatty liver disease (NAFLD, is the most commonly diagnosed form of liver disease in Hepatology clinics and often
associated with type II Diabetes Mellitus and Metabolic Syndrome. Whilst it is known that chronic liver disease (Cirrhosis)
is associated with Hepatocellular Carcinoma in most of liver diseases, in NAFLD however, the incidence and prevalence of
Hepatocellular Carcinoma is rising and hence, it is imperative that health care professionals endeavour to raise awareness on
preventative measures of the disease and the importance of early detection. This would ensure that NAFLD finds its place in
public discourse, to minimise the burden that such diseases have on the health system, in addition to the person affected by the
disease. Causative factors are plentiful, starting from a genetic predisposition (proven by the recurrence of the disease after liver
transplant) to environmental factors, not limited to obesity and lack of exercise, concluding with other pathologies, which are
notably the primary cause of NAFLD; namely Diabetes, Hyperlipidaemia, Insulin Resistance and Metabolic Syndrome, amongst
others. Diagnostic tools are available, accessible, affordable and non-invasive (such as blood markers and imaging). Previously,
treatment was limited to life style changes (exercise and diet), coupled with treating the associated diseases (Diabetes, Insulin
resistant and Hyperlipidaemia). This is no longer the case, with the introduction of specific medication recently, that is aimed at
reversing the histopathological as well as the biochemical abnormalities associated with the disease to prevent progression to
chronic liver disease (Cirrhosis with or without complications).
yg@mail.nankai.edu.cnJ Gastroenterol Dig Dis 2018, Volume 3